-A federal judge in Texas has upheld the U.S. Food and Drug Administration's decision to remove Novo Nordisk's blockbuster drugs Ozempic and Wegovy from the drug shortage list, rejecting a challenge ...

Type 2 diabetes patients taking semaglutide, often sold as Ozempic or Wegovy, have a slightly lower risk of stroke compared ...

They were designed to treat diabetes, then prescribed for weight loss, and now—as researchers are finding—they might hold the ...

Many focus on what weight-loss drugs take away: pounds. But they also offer patients something new: a sense of agency.

A total of 111 deaths were logged with the regulator, the Medicines and Healthcare products Regulatory Agency (MHRA), up to ...

Women who use an oral contraceptive might want to consider using a back-up method after starting a weight loss drug.

Researchers say people with schizophrenia are facing an "epidemic" of obesity-related diseases, with weight gain a common ...

Researchers have established a troubling link between semaglutide, the active ingredient in Ozempic and Wegovy, with suicidal ... in-house monitoring had found no "causal association" between ...

Drug regulators in Europe have found no evidence that popular diabetes and weight-loss drugs like Ozempic and Wegovy ... s no known tie between a new class of obesity drugs and suicide.

An evaluation regarding side effects from popular drugs used to treat diabetes and obesity showed no link to ... no known tie between obesity drugs like Ozempic and Wegovy and suicide.